©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Allosteric Modulation by Tertiary Structure in Mammalian Hemoglobins
INTRODUCTION OF THE FUNCTIONAL CHARACTERISTICS OF BOVINE HEMOGLOBIN INTO HUMAN HEMOGLOBIN BY FIVE AMINO ACID SUBSTITUTIONS (*)

(Received for publication, August 10, 1995; and in revised form, October 16, 1995)

Clara Fronticelli (1)(§) Maria Teresa Sanna (1) Gabriela C. Perez-Alvarado (1) Michael Karavitis (1) A-Lien Lu (1) William S. Brinigar (2)

From the  (1)Department of Biological Chemistry, University of Maryland, Medical School, Baltimore Maryland 21201 and the (2)Department of Chemistry, Temple University, Philadelphia, Pennsylvania 19122

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Bovine erythrocytes do not contain 2,3-diphosphoglycerate, the principal allosteric effector of human hemoglobin. Bovine hemoglobin has a lower oxygen affinity than human hemoglobin and is regulated by physiological concentrations of chloride (Fronticelli, C., Bucci, E., and Razynska, A.(1988) J. Mol. Biol. 202, 343-348). It has been proposed that the chloride regulation in bovine hemoglobin is introduced by particular amino acid residues located in the amino-terminal region of the A helix and in the E helix of the beta subunits (Fronticelli, C.(1990) Biophys. Chem. 37, 141-146). In accordance with this proposal we have constructed two mutant human hemoglobins, beta(V1M+H2deleted+T4I+P5A) and beta(V1M+H2deleted+T4I+P5A+A76K). These are the residues present at the proposed locations in bovine hemoglobin except for isoleucine at position 4. Oxygen binding studies demonstrate that these mutations have introduced into human hemoglobin the low oxygen affinity and chloride sensitivity of bovine hemoglobin and reveal the presence of a previously unrecognized allosteric mechanism of oxygen affinity regulation where all the interactions responsible for the lowered affinity and chloride binding appear to be confined to individual beta subunits.


INTRODUCTION

Hemoglobin (Hb) (^1)is present within the red cell at about 5 mM concentration and functions to transport oxygen from the lungs to the tissues (Antonini and Brunori, 1970). This protein is a tetramer composed of two pairs of identical alpha and beta subunits. The four subunits have the same tertiary folding, and they each contain eight alpha helices, which are identified as A through H. The tetrameric molecule can assume two conformations that are in equilibrium with one another. The predominant conformation when no oxygen is bound is called T state, and the predominant conformation when the oxygen is coordinated to the iron is termed R state. The affinity of the protein for oxygen is regulated by position of the conformational equilibrium, i.e. the equilibrium between the R and T states. The position of the conformational equilibrium is also influenced by pH and the concentration of certain anions, termed effectors. In the absence of effector anions, the oxygen affinity of human Hb is too high for efficient release of oxygen at the oxygen partial pressure maintained in most tissues, approximately 40 torr (Vandegriff, 1992).

In human Hb, the effector regulating the conformational equilibrium in the red cells is 2,3-diphosphoglycerate (DPG) (Benesch et al., 1968). On the other hand, bovine Hb has an intrinsically lower oxygen affinity than human Hb, and the affinity is lowered further by interaction with physiological concentrations of chloride ions (100-150 mM) (Fronticelli et al., 1984, 1988; Perutz et al., 1993). At this concentration of chloride, the oxygen affinity of bovine Hb is insensitive to polyanions such as DPG and has an oxygen affinity similar to that of human whole blood (Bucci et al., 1988).

In the development of hemoglobins to be used clinically as a cell-free oxygen carrier, an understanding of the molecular mechanism that regulates the functional characteristics of bovine Hb could lead to the design of human Hb variants that are capable of efficient oxygen transport in cell-free solutions within the circulatory system at the physiological chloride concentrations.

Searching for structural differences between the human and bovine hemoglobins, we examined their hydropathy plots (Fronticelli, 1990). No differences were detected between the alpha chains of human and bovine Hb; however, in the beta chains two regions of different hydrophobicities were observed. One comprised a portion of the A helix, and the other comprised a portion of the E helix. In order to correlate the different hydrophobicities with relevant differences in sequence, we compared sequences of several primate and ruminant beta subunits. The results, reported in Table 1, show the presence of consistently different sequences that in ruminant beta subunits result in an increase in the hydropathic index of the amino-terminal end of the protein and a decrease in the index of the E helix relative to human beta subunits. Thus, we hypothesized that amino acid substitutions of the amino-terminal residues and of the A and E helices of bovine Hb were responsible for introducing in bovine Hb a different mechanism of oxygen affinity regulation (Fronticelli, 1990).



To test this hypothesis we have constructed mutant human hemoglobins containing some of the amino acid substitutions reported in Table 1. Substitution of valine beta1 with a methionine and deletion of histidine beta2 produced a stabilization of the T state but was not sufficient to introduce the low oxygen affinity of bovine hemoglobin into human hemoglobin (Fronticelli, 1992). However, this mutation removed the Cl binding site between Val and Lys as well as the Cl-dependent Bohr effect and introduced at the amino-terminal of the human beta subunits the conformation present in bovine beta subunits (Fronticelli et al., 1994; Perutz et al., 1993). Additional amino acid substitutions have now been introduced, and in this paper we report the functional properties of two mutant hemoglobins, beta(V1M+H2deleted+T4I+P5A) and beta(V1M+H2deleted+T4I+ P5A+A76K).

Our results confirm the original hypothesis that the functional characteristics of bovine hemoglobin are principally dependent on the presence of specific amino acid residues in the A and E helices. Most important, they also reveal a novel mechanism of oxygen affinity modulation within a single beta subunits, regulated by tertiary conformational changes.


MATERIALS AND METHODS

Protein Cloning, Expression, and Purification

The plasmid bearing the beta globin mutations, M1V, H2 deleted, T4I, and P5A, was generated from pJKO5, which contains the beta globin cDNA fused to a Factor X recognition sequence and a truncated flu virus protein, NS1 (Fronticelli et al., 1991). pJKO5 has only two Bsu36I (MstII) sites, both within the globin gene. The first Bsu36I site is in the region of the Pro^5 codon, 33 nucleotide residues downstream from the single NcoI site, which is at the juncture between NS1 gene and the Factor X recognition sequence. The second Bsu36I site is 159 nucleotide residues beyond the first. The vector was prepared by first digesting pJKO5 exhaustively with NcoI followed by a partial digestion with Bsu36I, and the DNA was gel purified. The recognition sequence of Bsu36I is 5`-CCTXAGG and is not the same in the two beta globin sites; the first is CCTGAGG and the second is CC TAAGG. Therefore, in the vector, Bsu36I generates a 5`TGA- overhang at the first site and a 5`TTA- overhang at the second site. Taking advantage of this difference, a double stranded oligonucleotide was designed that would anneal and ligate selectively to the first site. Accordingly, two oligonucleotides were synthesized that coded for the sequence changes indicated above, were complementary, and had a 5`-CATG (NcoI) overhang on the one end with a 3`-ACT-5` overhang on the other. These two oligonucleotides were phosphorylated with polynucleotide kinase, annealed, and ligated into pJKO5, which had been digested with NcoI and Bsu36I as described above. Colonies were screened for the correct size NcoI to EcoRV fragment containing the full-length beta globin gene, as well as the absence of a PvuI site, which was purposefully omitted from the Factor X region of the mutagenic oligonucleotide.

Synthesis of the mutant NS1-FX-beta globin fusion protein was obtained in Escherichia coli strain AR-120, induced with nalidixic acid as described previously (Fronticelli et al., 1991). The molecular weight of the fusion protein and the amount produced were indistinguishable in SDS-polyacrylamide gel electrophoresis from that produced from pJKO5 under the same conditions. The DNA was sequenced by the dideoxy method through the region of the mutagenic oligonucleotide confirming the mutations indicated above. The additional mutation, A76K, was introduced using the method of Kunkel et al. (1987) and the Bio-Rad Muta-Gene mutagenesis kit.

Cleavage of the isolated fusion protein with Factor Xa and reconstitution with cyano hemin and alpha subunits were carried out as described previously (Fronticelli et al., 1991). All of the amino acid substitutions were confirmed by peptide sequencing. The beta globin from human Hb and beta(PB5) were purified by reverse phase HPLC (Shelton et al., 1984) on a Vydac 4 column using a gradient of 0.1% trifluoroacetic acid with an increasing concentration of acetonitrile. In each case the protein was S-pyridylethylated and digested with trypsin treated with 1-tosylamide-2-phenylethyl chloromethlyl ketone. The tryptic peptides were separated by HPLC and analyzed as described previously (Bucci et al., 1993). Sequential Edman degradation was carried out on a Hewlett Packard G1000A sequenator.

Preparation of Human-Bovine Hybrids

Hybrids alpha(bovine)(2)beta(human)(2) and alpha(human)(2)beta(bovine)(2) were obtained by mixing, in the presence of free heme, the native human subunits with the partner alpha or beta bovine globins. Human native subunits were prepared according to the methods of Bucci and Fronticelli(1965). This method cannot be used with bovine hemoglobin, which does not have cysteine residues at the alpha1beta1 interface, and the bovine alpha and beta globins were separated by reverse phase chromatography (Fronticelli et al., 1990). The peak containing the beta globin was dialyzed against water, the precipitate collected, solubilized in 0.1 M NaOH and dialyzed under nitrogen against 0.04 M borate buffer at pH 9.0 containing 1 mM dithioerythritol and 1 mM EDTA. The bovine beta globin was reconstituted into tetrameric hemoglobin upon the addition of an equimolar amount of heme and human alpha subunits. The bovine alpha globin after dialysis against water was dissolved in 5 mM acetic acid and dialyzed against 20 mM phosphate buffer at pH 5.5 and reconstituted with heme and human beta subunits. The reconstituted hybrid proteins were purified on ion exchange chromatography (Fronticelli et al., 1991). The Paragon electrophoresis system (Beckman) was used to confirm the degree of purity.

Oxygen Equilibrium Curves

These data were obtained using the thin layer dilution technique (Dollman and Gill, 1978). The protein concentration was 20-30 mg/ml at 25 °C. The buffer was 50 mM Hepes. Effectors were added as specified in the legends of the figures. The experimental data were fitted to the Adair equation (Adair, 1925) as shown by the continuous lines in the figures.


RESULTS AND DISCUSSION

Hybrids of Human and Bovine Hemoglobin

We have constructed two human-bovine hemoglobin hybrids, alpha(bovine)(2)beta(human)(2) and alpha(human)(2)beta(bovine)(2) (Fronticelli, 1992). Fig. 1shows their electrophoretic behavior as compared with that of native human and bovine hemoglobins. Their mobility reflects the total charge difference based on the amino acid composition of the individual subunits.


Figure 1: Electrophoretic separation (Paragon system, Beckman) of human Hb (lane 1), bovine Hb (lane 2), alpha(bovine)(2)beta(human)(2) (lane 3), and alpha(human)(2)beta(bovine)(2) (lane 4). The dots represent the site of the samples deposition.



The rationale for the experiment was that if the entire molecule is necessary for expressing the decrease in oxygen affinity, the two hybrids would have similar oxygen affinities. Otherwise it would be found only in the hybrid containing the enabling subunit.

The hybrid containing the bovine beta chains has a 3-fold decrease in oxygen affinity (Fronticelli, 1992) with respect to the hybrid containing the human beta chains (Fig. 2). This is the same oxygen affinity difference observed between bovine and human Hb (Fronticelli et al., 1984), supporting the proposition that the reduced oxygen affinity of bovine Hb is expressed via the beta subunits.


Figure 2: Oxygen binding curves of hybrids of alpha(bovine)(2)beta(human)(2) (circles) and alpha(human)(2)beta(bovine)(2) (squares). Buffer, 100 mM Hepes with 100 mM Cl at pH 7.4. Temperature, 25 °C.



Pseudobovine Hemoglobins

We have constructed two mutant hemoglobins, both with normal human alpha subunits. In the first mutant, beta(V1M+H2del+T4I+P5A), hereafter abbreviated beta(PB4), valine beta1 was replaced by a methionine, histidine beta2 was deleted, proline beta5 was substituted by alanine, and, in order to further increase the hydrophobicity of the A helix, threonine beta4 was replaced by isoleucine. The second mutant, beta(V1M+H2del+T4I+P5A+A76K), abbreviated beta(PB5), has the sequence modifications of beta(PB4) plus the substitution of alanine beta76 to lysine. With the exception of the threonine beta4 to isoleucine substitution, all the residue changes are those found in the beta subunits of bovine Hb.

Peptide Analysis

The amino acid substitutions in the recombinant beta globin were confirmed by peptide analysis and sequencing. In Fig. 3the comparison of the peptide maps shows that peptide 1 is eluted at 54 and 65 min in the beta globins of human Hb and beta(PB5), respectively. Also, peptide 9 is split into two peptides, 9a and 9b, in beta(PB5), where a lysine is present at position 76. The rest of the peptide maps are identical in profile. Table 2shows the sequencing of peptides 1 and 9 from human Hb and beta(PB5).


Figure 3: Tryptic peptide maps of beta chains of human Hb (a) and of beta(PB5) (b).





Functional Data

In the absence of chlorides, beta(PB4), beta(PB5), and bovine Hb all have the same oxygen affinity, which is 3-fold lower than in human Hb (Fig. 4A). This result indicates that the amino acid substitutions present in beta(PB4) produce a stabilization of the T state sufficient for introducing into human Hb the intrinsic low oxygen affinity of bovine Hb. X-ray crystallography of bovine Hb and of the double mutant beta(V1M+H2deleted) suggests that this effect is due to a conformational change in the A helix that mimics the effect of DPG in human Hb (Perutz et al., 1993; Fronticelli et al., 1994)


Figure 4: Oxygen binding curves at pH 7.4 and protein concentration of 30 mg/ml. Temperature, 25 °C. A, human Hb (circles), beta(PB4) (triangles), beta(PB5) (squares), and bovine Hb (times). Buffer, 50 mM Hepes. B, human hemoglobin (circles), beta(PB4) (triangles), beta(PB5) (squares), and bovine hemoglobin (times). Buffer, 50 mM Hepes and 200 mM Cl. C, human hemoglobin (circles) and beta(PB5) (squares) in the absence (open symbols) and in the presence (filled symbols) of 2 mM DPG. Buffer, 50 mM Hepes and 100 mM Cl.



In the presence of 200 mM chloride, the oxygen affinity of human Hb is decreased; however, the oxygen affinity of beta(PB4) remains nearly the same as that observed in the absence of chloride (Fig. 4B). This result demonstrates that although the bovine-like sequence of the amino-terminal region lowers the oxygen affinity, it also greatly decreases the sensitivity to chloride. This latter property is not unexpected because we have previously shown that the replacement of Val Met and the deletion of His destroys the anion binding site between Val and Lys as well as the chloride-dependent Bohr effect (Fronticelli et al., 1994). In contrast to beta(PB4), the oxygen affinities of both bovine Hb and beta(PB5) are decreased to the same extent in the presence of 200 mM Cl (Fig. 4B). Clearly, the additional substitution of Ala Lys in beta(PB5) creates a new chloride-dependent regulatory site. A possible location of the chloride binding site is between Lys, Lys, and perhaps His of the same beta subunit, as earlier proposed (Fronticelli, 1990). The same Cl binding site has been postulated to be present in pig hemoglobin, where these three residues are also present. (Condo et al., 1992; Katz et al., 1994)

In the presence of 100 mM Cl, the oxygen affinity of beta(PB5) is 3-fold lower than the oxygen affinity of human Hb but similar to the oxygen affinity of human Hb in the presence of 2 mM DPG (Fig. 4C). Like bovine Hb in presence of 100 mM Cl, the oxygen affinity of beta(PB5) is virtually unaffected by the presence of 2 mM DPG (Fronticelli et al., 1988; Perutz et al., 1993). This indicates that the amino acid substitutions in beta(PB5) have introduced a mechanism of oxygen affinity modulation similar to the one present in bovine Hb.

Fig. 5presents the Cl titration of beta(PB4), beta(PB5), human Hb, and bovine Hb, in 50 mM Hepes buffer at pH 7.4. From the slope of the curve, it can be calculated (Wyman, 1964) that the Cl exchanged is 2.5/tetramer for human Hb, bovine Hb, and beta(PB5). This indicates that these hemoglobins bind the same number of chloride ions. In beta(PB4) the Cl exchanged is only 0.8/tetramer. This confirms that the replacement of Val with Met and the deletion of His results in the loss of the Cl binding site present at Val in human Hb (Fronticelli et al., 1994) and indicates that a new chloride binding site is introduced in beta(PB5) by the mutation Ala Lys.


Figure 5: Chloride titration of human Hb (circles), beta(PB4) (triangles), beta(PB5) (squares), and bovine Hb (times) in 50 mM Hepes at pH 7.4 at 25 °C.



Conclusion

These results are consistent with the proposition that the mechanism of oxygen transport in bovine Hb has its molecular basis on the presence of particular amino acid residues in the A and E helices of the beta subunits. (Fronticelli, 1990). The results indicate that the low oxygen affinity of bovine Hb compared with human Hb is due to the sequence of the amino-terminal end, which stabilizes a low affinity conformation independent of heterotropic effectors and that the Cl sensitivity is due to the formation of an oxygen-linked Cl binding site involving a lysine at position beta76 in the E helix. Crystallographic data on the deoxy human mutant beta(V1M+H2del) show that the presence of a methionine at position beta1 and the deletion of histidine at position beta2 places the amino terminus in close proximity to Asp (Fronticelli et al., 1994), thereby weakening the interaction present between Asp and Lys. Thus, Lys acquires a greater conformational flexibility and can establish with Lys a new Cl binding site, which provides additional stability to the tertiary conformation that was imposed on the beta subunits by the amino-terminal residues of the A helix. Upon oxygenation the interaction between Met and Asp would be disrupted (Fronticelli et al., 1994), the interaction between Lys and Asp would be re-established, and the Cl would be released.

Fig. 6A shows the electrostatic potential of the proposed Cl binding site calculated from the structure of the double mutant beta(V1M+H2del) (Fronticelli et al., 1994) using the program GRASP (Nicholls et al., 1991). The substitution Ala Lys was manually introduced, and the side chain of Lys was repositioned. A positively charged cleft is observable between Lys and Lys. These two residues are about 11 Å apart and can be bridged by a Cl ion (Van der Waals radius, 2.5 Å). Fig. 6B shows the electrostatic potential of the same region in deoxy human Hb, where the putative Cl binding site is clearly absent. This model is at variance with the proposition that the mechanism of the chloride linked cooperative effects is the same in human and bovine hemoglobins (Perutz et al., 1993).


Figure 6: Electrostatic potential shown from -8 kT (red) to +8kT (blue), calculated using the program GRASP (Nicholls et al., 1991). A, proposed Cl binding site calculated from the coordinates of the double mutant beta(V1M+H2del) (code 2hhe). The substitution Ala Lys was manually introduced. B, electrostatic potential of the same site in deoxy human Hb (code 2hhd), where an alanine is present at beta76.



It should be emphasized that all the interactions that generate bovine Hb-like properties in beta(PB5) appear to be localized in individual beta subunits. Thus, these data present evidence for the presence of an allosteric mechanism of oxygen affinity modulation regulated solely by tertiary conformational changes. Notably, although there are 24 amino acid differences between the human and bovine beta globins, this mechanism is introduced into human Hb by the replacement of only five amino acid residues.


FOOTNOTES

*
The work was supported by United States Public Health Service Grant PO1-HL48517. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

This paper is dedicated to the memory of Professor Jeffries Wyman, beloved teacher and friend.

§
To whom correspondence should be addressed: Dept. of Biochemistry, University of Maryland, Medical School, 108 North Greene St., Baltimore MD, 21201. Phone: 410-706-7672; Fax: 410-706-7390; cfrontic@umabnet.ab.umd.edu.

(^1)
The abbreviations used are: Hb, hemoglobin; DPG, 2,3-diphosphoglycerate; beta(PB4), mutant human hemoglobin beta(V1M+H2del+T4I+P5A); beta(PB5), mutant human hemoglobin beta(V1M+H2del+T4I+P5A+A76K); HPLC, high pressure liquid chromatography.


ACKNOWLEDGEMENTS

We are grateful to Dr. Walter Kisiel (University of New Mexico) for the gift of Factor Xa and to Dr. Anna Razynska (University of Maryland) for the amino acids sequencing.


REFERENCES

  1. Adair, J. S. (1925) J. Biol. Chem. 63, 529-545
  2. Antonini and Brunori (1970) in Hemoglobin and Myoglobin in their Reaction with Ligands (Neuberger, A., and Tatum, E. L., eds) North Holland Publishing Co., Amsterdam
  3. Benesch, R., Benesch, M. E., and Yu, C. I. (1968) Proc. Natl. Acad. Sci. U. S. A. 59, 526-532 [Medline]
  4. Bucci, E., and Fronticelli, C. (1965) J. Biol. Chem. 240, 551-552
  5. Bucci, E., Fronticelli, C., Orth, C., Martorana, C., Aebischer, L., and Angeloni, P. (1988) Biomater. Artif. Cells Artif. Organs 16, 197-204
  6. Bucci, E., Fronticelli, C., Gryczynski, Z., Razynska, A., and Collins, J. H. (1993) Biochemistry 32, 3519-3526 [Medline]
  7. Condo, S. G., Corda, M., Sanna, M. T., Pellegrini, M. G., Ruiz, M. P., Castagnola, M., and Giardina, B. (1992) Eur. J. Biochem. 209, 773-776 [Medline]
  8. Dolman, D., and Gill, S. J. (1978) Anal. Biochem. 87, 127-134
  9. Fronticelli, C. (1990) Biophys. Chem. 37, 141-146 [Medline]
  10. Fronticelli, C. (1992) in Techniques in Protein Chemistry III (Angeletti, R. H., ed) pp. 399-406, Academic Press, San Diego, CA
  11. Fronticelli, C., Bucci, E., and Orth, C. (1984) J. Biol. Chem. 259, 10841-10844 [Medline]
  12. Fronticelli, C., Bucci, E., and Razynska, A. (1988) J. Mol. Biol. 202, 343-348 [Medline]
  13. Fronticelli, C., Bucci, E., Razynska, A., Sznajder, J., Urbaitis, B., and Gryczynski, Z. (1990) Eur. J. Biochem. 193, 331-336 [Medline]
  14. Fronticelli, C., O'Donnell J. K., and Brinigar W. S. (1991) J. Protein Chem. 10, 495-501 [Medline]
  15. Fronticelli, C., Pechik, I., Brinigar, W. S., Kowalczyk, J., and Gilliland, G. (1994) J. Biol. Chem. 269, 23965-23969 [Medline]
  16. Katz, D. S., White, S. P., Huang, W., Kumar, R., and Christianson, D. W. (1994) J. Mol. Biol. 244, 541-553 [Medline]
  17. Kunkel, T. A., Roberts, J. D., and Zakatour, R. H. (1987) Methods Enzymol. 154, 367-382 [Medline]
  18. Nicholls, A., Sharp, K. A., and Honig, B. (1991) Proteins Struct. Funct. Genet. 11, 281-296
  19. Perutz, M. F., Fermi, G., Poyart, C., Pagnier, J., and Kister, J. (1993) J. Mol. Biol. 232, 536-545
  20. Shelton, J. B., Shelton, J. R., and Schroeder, W. A. (1984) J. Liq. Chromatogr. 7, 1969-1977
  21. Vandegriff, K. D. (1992) Biotechnol. & Genet. Eng. Rev. 10, 403-453 [Medline]
  22. Wyman, J. (1964) Adv. Protein Chem. 19, 223-286

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.